Category of exposure to HIV and age in the progression to AIDS: Longitudinal study of 1199 people with known dates of seroconversion

British Medical Journal

Volumn 313, Issue 7057, 1996, Pages 583-586

  Pezzotti, Patrizio ^a   Phillips, Andrew N ^b   Dorrucci, Maria ^a   Lepri, Alessandro Cozzi ^a   Galai, Noya ^c   Vlahov, David ^d,e   Rezza, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c HEBREW UNIVERSITY   (Israel)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e Department of Epidemiology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE CONTROL; DISEASE COURSE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SEROCONVERSION; STATISTICAL ANALYSIS;

EID: 0029812846     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7057.583     Document Type: Article

References (32)

1. Multicohort Analysis Project Workshop. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. AIDS 1994; 8:911-21.
2. Jason J, Lui KJ, Ragni MV, Hessol NA, Darrow WW. Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men. JAMA 1989;261:725-7.
3. Biggar RJ, International Registry of Seroconverters. AIDS incubation in 1891 HIV seroconverters from different exposure groups. AIDS 1990; 4:1059-66.
4. Rosenberg PS, Goedert JJ, Biggar RJ for the Multicenter Hemophilia Cohort Study and the International Registry of Seroconverters. Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS 1994;8:803-10.
5. Giesecke J, Scalia-Tomba G, Berglund O, Berntorp E, Schulman S, Stigendal L. Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. BMJ 1988;297:99-102.
6. Carré K, Deveau C, Belanger F, Boufassa F, Persoz A, Jadand G, et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994;8:797-802.
7. Mariotto AB, Mariotti S, Pezzotti P, Rezza G, Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol 1992;135:428-37.
8. Pezzotti P, Rezza G, Lazzarin A, Angarano G, Siniceo A, Aiuti F, et al. Influence of gender, age and transmission category on the progression from HIV seroconversion to AIDS. J Acquir Immune Defic Syndr 1992; 5:745-7.
9. Rezza G, Dorrucci M, Pezzotti P, Lazzarin A, Angarano G, Siniceo A, et al. The seroconversion study on the natural history of HIV infection. In: Nicolosi A, ed. HIV epidemiology: models and methods. New York: Raven Press, 1994:279-89.
10. Vella S, Giuliano M, Floridia M, Chiesi A, Tomino C, Seeber A, et al. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. AIDS 1995;9:51-6.
11. Von Overbeck J, Egger M, Davey Smith G, Schoep M, Ledergerber B, Furrer H, et al. Survival in HIV infection: do sex and category of transmission matter? AIDS 1994;8:1307-13.
12. Eskild A, Magnus P, Sohlberg C, Jensen F, Kittelsen P. A comparison of the progression rate to acquired immunodeficiency syndrome between intravenous drug users and homosexual men. Scand J Soc Med 1994;4:309-14.
13. Operskalski EA, Stram DO, Lee H, Zhu Y, Donegan E, Busch MP, et al. Human immunodeficiency virus type 1 infection: relation of risk group and age to rate of progression to AIDS. J Infect Dis 1995;172:648-55.
14. Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med 1995;333:751-6.
15. Veugelers PJ, Strathdee SA, Tindall B, Page KA, Moss R, Schechter MT, et al. Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV-infected homosexual men. AIDS 1994;8:1471-5.
16. Rezza G, Lazzarin A, Angarano A, Siniceo A, Pristera R, Ortona L, et al. The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters. AIDS 1989;3:87-90.
17. Centers for Diseases Control. Revision of the CDC surveillance case definition for AIDS. MMWR Morb Mortal Wkly Rep 1987;36:1-5s.
18. Ancelle-Park R. Expanded European AIDS case definition. Lancet 1993;341: 441.
19. Lee ET. Statistical methods for survival data analysis. 2nd ed. New York: John Wiley and Sons, 1992.
20. 11/1 but free of AIDS-defining clinical disease. AIDS 1994;8:1577-83.
21. The Italian Seroconversion Study. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users AIDS 1992;6:421-6.
22. Weinberg K, Parkman R. Age, the thymus, and T lymphocytes. N Engl J Med 1995;332:182-3.
23. + T-lymphocytes regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-9.
24. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
25. + lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
26. Peterson PK, Sharp BM, Gekker G. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell co-cultures. AIDS 1990;4:869-74.
27. Donahoe RM, Nicholson JK, Madden JJ, Donahoe F, Schafer DA, Gordon D, et al. Coordinate and independent effects of heroin, cocaine and alcohol abuse on T-cell E-rosette formation and antigenic marker expression. Clin Immunol Immunopathol 1986;41:254-64.
28. Mientjes GH, Miedema F, Van Ameijder EJ. Frequent injecting impairs lymphocyte reactivity in HIV seropositive and HIV negative drug users. AIDS 1991,5:35-41.
29. Brown SM, Stimmel B, Tabu RN, Taub RN, Kochwa S, Rosenfeild RE. Immunologic dysfunction in heroin addicts. Arch Intern Med 1974;134:1001-6.
30. Galai N, Vlahov D, Margolick JB, Chen K, Graham NMH, Muñoz A. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr 1995;8:66-74.
31. + homosexual men and injecting drug users studied in a single laboratory. Arch Intern Med 1994;154:869-75.
32. Bofill M, Janossy G, Lee CA, MacDonald-Burn D, Phillips AN, Sabin C, et al. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol 1992;88:243-52.